• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于简单临床观察指标对系统性硬化症相关肺动脉高压的预测

Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations.

作者信息

Meune Christophe, Avouac Jérôme, Airò Paolo, Beretta Lorenzo, Dieudé Philippe, Wahbi Karim, Caramaschi Paola, Tiev Kiet, Cappelli Susanna, Diot Elisabeth, Vacca Alessandra, Cracowski Jean-Luc, Sibilia Jean, Kahan André, Matucci-Cerinic Marco, Allanore Yannick

机构信息

Paris Descartes University and Department of Rheumatology A, Cochin Hospital, AP-HP, Paris, France.

出版信息

Arthritis Rheum. 2011 Sep;63(9):2790-6. doi: 10.1002/art.30432.

DOI:10.1002/art.30432
PMID:21547892
Abstract

OBJECTIVE

To develop a score to estimate the risk of developing pulmonary hypertension (PH) in patients with systemic sclerosis (SSc).

METHODS

We first examined the prevalence and characteristics of precapillary PH confirmed by right-heart catheterization in a cross-sectional (derivation) sample of 1,165 SSc patients, and we developed a risk prediction score (RPS) based on simple clinical observations associated with PH. We next prospectively tested the 3-year predictive power of the "Cochin RPS" in a separate (validation) sample of 443 patients presenting with PH-free SSc at baseline.

RESULTS

In the derivation sample, age, forced vital capacity, and diffusing capacity for carbon monoxide/alveolar volume were independently associated with the presence of PH and were used to create the Cochin RPS. PH developed during followup in 20 patients in the validation sample. The area under the receiver operating characteristic curve of the Cochin RPS was 0.87 (95% confidence interval 0.79-0.95). With a cutoff value of 2.73, patients at risk of PH during followup could be identified with 89.5% sensitivity and 74.1% specificity. PH occurred in 0.6% of patients in the lowest 2 quintiles of the Cochin RPS, in 1.7% of patients in the third and fourth quintiles, and in 17.1% of patients in the highest quintile (P<0.0001 by log rank test). Patients in the highest quintile incurred a >35-fold higher risk of developing PH compared with patients in the 2 lowest quintiles (P=0.001).

CONCLUSION

Using routine clinical observations, we developed a simple score that accurately predicted the risk of PH in SSc.

摘要

目的

制定一个评分系统,以评估系统性硬化症(SSc)患者发生肺动脉高压(PH)的风险。

方法

我们首先在1165例SSc患者的横断面(推导)样本中,研究经右心导管检查确诊的毛细血管前性PH的患病率和特征,并基于与PH相关的简单临床观察结果制定了风险预测评分(RPS)。接下来,我们在另一个(验证)样本中对443例基线时无PH的SSc患者进行前瞻性测试,以检验“科钦RPS”的3年预测能力。

结果

在推导样本中,年龄、用力肺活量以及一氧化碳弥散量/肺泡容积与PH的存在独立相关,并用于创建科钦RPS。在验证样本的随访期间,有20例患者发生了PH。科钦RPS的受试者工作特征曲线下面积为0.87(95%置信区间0.79 - 0.95)。截断值为2.73时,随访期间有PH风险的患者可被识别,灵敏度为89.5%,特异度为74.1%。在科钦RPS最低的两个五分位数组中,0.6%的患者发生了PH;在第三和第四五分位数组中,1.7%的患者发生了PH;在最高五分位数组中,17.1%的患者发生了PH(对数秩检验P<0.0001)。与最低的两个五分位数组中的患者相比,最高五分位数组中的患者发生PH的风险高35倍以上(P = 0.001)。

结论

通过常规临床观察,我们制定了一个简单的评分系统,能够准确预测SSc患者发生PH的风险。

相似文献

1
Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations.基于简单临床观察指标对系统性硬化症相关肺动脉高压的预测
Arthritis Rheum. 2011 Sep;63(9):2790-6. doi: 10.1002/art.30432.
2
Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension.系统性硬化症患者的临界平均肺动脉压:跨肺压差可预测发生肺动脉高压的风险。
Arthritis Rheum. 2013 Apr;65(4):1074-84. doi: 10.1002/art.37838.
3
Stress Doppler echocardiography in systemic sclerosis: evidence for a role in the prediction of pulmonary hypertension.系统性硬化症中的应激多普勒超声心动图:在预测肺动脉高压中作用的证据
Arthritis Rheum. 2013 Sep;65(9):2403-11. doi: 10.1002/art.38043.
4
High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.高N末端脑钠肽前体水平和低一氧化碳弥散能力作为系统性硬化症患者毛细血管前肺动脉高压发生的独立预测因素。
Arthritis Rheum. 2008 Jan;58(1):284-91. doi: 10.1002/art.23187.
5
Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests.利用肺功能测试提高系统性硬化症中肺动脉高压的检测率。
Arthritis Rheum. 2011 Nov;63(11):3531-9. doi: 10.1002/art.30535.
6
Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.系统性硬化症患者肺动脉高压的评估:非侵入性检查与右心导管检查结果的比较。
J Rheumatol. 2008 Mar;35(3):458-65. Epub 2008 Jan 15.
7
Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.合并和不合并间质性肺疾病的系统性硬化症中重度肺动脉高压的患病率及特征
J Rheumatol. 2007 May;34(5):1005-11. Epub 2007 Apr 15.
8
Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.硬皮病中间质性肺疾病和肺动脉高压患者6分钟步行试验的局限性
J Rheumatol. 2009 Feb;36(2):330-6. doi: 10.3899/jrheum.080447. Epub 2009 Jan 22.
9
Delayed gastric emptying determined using the 13C-octanoic acid breath test in patients with systemic sclerosis.采用13C-辛酸呼气试验测定系统性硬化症患者的胃排空延迟情况。
Arthritis Rheum. 2012 Jul;64(7):2346-55. doi: 10.1002/art.34374.
10
Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.与间质性肺疾病相关的系统性硬化症相关性肺动脉高压:肺动脉高压治疗的影响
Arthritis Rheum. 2011 Aug;63(8):2456-64. doi: 10.1002/art.30423.

引用本文的文献

1
Potential role of exercise echocardiography and right heart catheterization in the detection of early pulmonary vascular disease in patients with systemic sclerosis.运动超声心动图和右心导管检查在系统性硬化症患者早期肺血管疾病检测中的潜在作用
J Scleroderma Relat Disord. 2019 Oct;4(3):219-224. doi: 10.1177/2397198319849805. Epub 2019 May 24.
2
Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosis.系统性硬化症患者诊断后前5年器官受累情况及生存率的预测
J Scleroderma Relat Disord. 2020 Feb;5(1):57-65. doi: 10.1177/2397198319869564. Epub 2019 Sep 6.
3
A normal diffusing capacity of the lungs for carbon monoxide is rare in incidental pulmonary arterial hypertension in systemic sclerosis: Data from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma cohort.
在系统性硬化症伴发的肺动脉高压中,肺一氧化碳弥散能力正常的情况罕见:来自硬皮病队列中肺动脉高压评估与结局识别研究的数据。
J Scleroderma Relat Disord. 2018 Oct;3(3):237-241. doi: 10.1177/2397198318778818. Epub 2018 Jun 1.
4
Screening for Pulmonary Hypertension in Systemic Sclerosis-A Primer for Cardio-Rheumatology Clinics.系统性硬化症中肺动脉高压的筛查——心血管风湿病诊所入门指南
Diagnostics (Basel). 2021 Jun 1;11(6):1013. doi: 10.3390/diagnostics11061013.
5
Systemic Sclerosis and Pulmonary Disease.系统性硬化症与肺部疾病。
Adv Exp Med Biol. 2021;1303:173-182. doi: 10.1007/978-3-030-63046-1_10.
6
The Utility of Plasma Vascular Biomarkers in Systemic Sclerosis: A Prospective Longitudinal Analysis.血浆血管生物标志物在系统性硬化症中的效用:一项前瞻性纵向分析。
Arthritis Rheumatol. 2020 Aug;72(8):1341-1349. doi: 10.1002/art.41265. Epub 2020 Jul 20.
7
Vascular complications in systemic sclerosis: a prospective cohort study.系统性硬皮病的血管并发症:一项前瞻性队列研究。
Clin Rheumatol. 2018 Sep;37(9):2429-2437. doi: 10.1007/s10067-018-4148-5. Epub 2018 May 26.
8
Six-Minute Walk Test as a Predictor of Diagnosis, Disease Severity, and Clinical Outcomes in Scleroderma-Associated Pulmonary Hypertension: The DIBOSA Study.六分钟步行试验作为硬皮病相关肺动脉高压诊断、疾病严重程度及临床结局的预测指标:DIBOSA研究
Lung. 2017 Oct;195(5):529-536. doi: 10.1007/s00408-017-0034-1. Epub 2017 Jun 23.
9
Undiagnosed connective tissue diseases: High prevalence in pulmonary arterial hypertension patients.未确诊的结缔组织病:在肺动脉高压患者中患病率高。
Medicine (Baltimore). 2016 Sep;95(39):e4827. doi: 10.1097/MD.0000000000004827.
10
Advances in pathogenesis and treatment of systemic sclerosis.系统性硬化症的发病机制与治疗进展
Clin Med (Lond). 2016 Feb;16(1):55-60. doi: 10.7861/clinmedicine.16-1-55.